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ABSTRACT 
Mutations in the leucine-rich, glioma inactivated 1 (LGI1) gene have been 
identified in patients with autosomal dominant lateral temporal lobe 
epilepsy (ADLTE). We previously reported that Lgi1 mutant rats, carrying 
a missense mutation (L385R) generated by gene-driven 
N-ethyl-N-nitrosourea (ENU) mutagenesis, showed generalized 
tonic-clonic seizures (GTCS) in response to acoustic stimuli. In the present 
study, we assessed clinically-relevant features of Lgi1 heterozygous 
mutant rats (Lgi1L385R/+) as an animal model of ADLTE. First, to explore 
the focus of the audiogenic seizures, we performed electroencephalography 
(EEG) and brain Fos immunohistochemistry in Lgi1L385R/+ and wild type 
rats. EEG showed unique seizure patterns (e.g., bilateral rhythmic spikes) 
in Lgi1L385R/+ rats with GTCS. An elevated level of Fos expression 
indicated greater neural excitability to acoustic stimuli in Lgi1L385R/+ 
rats, especially in the temporal lobe, thalamus and subthalamic nucleus. 
Finally, microarray analysis revealed a number of differentially expressed 
genes that may be involved in epilepsy. These results suggest that 
Lgi1L385R/+ rats are useful as an animal model of human ADLTE. 
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>EEG of Lgi1L385R/+ rats shows patterns that correspond to seizure behavior. 
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Autosomal dominant lateral temporal lobe epilepsy (ADLTE) is a rare 
familial partial epilepsy syndrome mainly reported in Europe, the United 
States, Australia and Japan (Kawamata et al., 2009). The estimated 
penetrance ranges widely from 51 to 80% (Ottman et al., 1995; Ottman et al., 
2004; Michelucci et al., 2009). ADLTE is characterized by focal seizures with 
auditory auras such as simple sound or auditory hallucinations in 55–64% of 
cases (Michelucci et al., 2003; Ottoman et al., 2004). Secondarily generalized 
tonic-clonic seizures (GTCS) are seen in 90% of cases (Michelucci et al., 2009). 
In some patients, seizures are induced by acoustic stimuli such as sudden 
noises or answering the phone (Winawer et al., 2000; Michelucci et al., 2003; 
Michelucci et al., 2007), indicating a lateral temporal lobe onset. Some MRI 
studies have reported developmental abnormalities in the left lateral 
temporal lobe of patients (Kobayashi et al., 2003; Tessa et al., 2007). Fujita et 
al. (2009) also found left lateral temporal lobe hypometabolism using 
FDG-PET, and Brodtkorb et al. (2005) reported a predominance of left 
temporal EEG abnormalities. In addition, a mutation in the leucine-rich, 
glioma inactivated 1 (LGI1) gene has recently been reported to be a cause of 
ADLTE (Kalachikov et al., 2002; Morante-Redolat et al., 2002), and 
Kawamata et al. (2009) reported two ADLTE families with LGI1 mutations 
in Japan. 
Lgi1 null knockout mice show spontaneous seizures and die within 20 days 
of birth, while heterozygous Lgi1 mice do not have spontaneous seizures, but 
show auditory stimulus-induced seizures (Fukata et al., 2010). A lack of Lgi1 
also reduces synaptic transmission mediated by AMPA, ADAM22, and 
ADAM23 receptors in the hippocampus (Fukata et al., 2010) and enhances 
excitatory synaptic transmission by increasing the release of glutamate (Yu 
et al., 2010). Seizure-induced damage, such as neuronal loss, mossy fiber 
sprouting, astrocyte reactivity and granule cell dispersion in the 
hippocampus after recurrent seizures, was also reported in Lgi1-/- mice 
(Chabrol et al., 2010). Rat models, because of their larger brains, are useful 
for studying clinically relevant features such as the detection of seizure foci. 
We therefore generated an Lgi1 missense mutant (L385R) rat on an F344 
background by N-ethyl-N-nitrosourea mutagenesis (Baulac et al., 2012). Lgi1 
homozygous (Lgi1L385R/L385R) mutant rats have spontaneous seizures after 
postnatal day (P) 10 and die prematurely (by P17). Although Lgi1 
heterozygous (Lgi1L385R/+) mutant rats do not have spontaneous seizures, all 
Lgi1L385R/+ rats primed with acoustic stimuli at P16 displayed wild running 
behavior and subsequent GTCS after exposure to acoustic test stimuli at 8 
weeks (Baulac et al., 2012).  
Here, we describe further study of the Lgi1L385R/+ mutant rat, using 
electroencephalography (EEG) and Fos-immunoreactivity (Fos-IR) to 
identify the foci of audiogenic seizures (AGS), and microarray analysis to 
identify candidate genes that may be responsible for AGS. 
 
2. Materials and methods 
2.1. Experimental animals 
Lgi1 mutant rats carrying a heterozygous missense mutation (L385R/+) 
(strain name, F344-Lgi1m1kyo) (Baulac et al., 2012), and wild type (WT) 
F344/NSlc rats were bred and maintained at the Institute of Laboratory 
Animals, Graduate School of Medicine, Kyoto University, in air-conditioned 
rooms under a 14-h light/10-h dark cycle. Animal care and experiments 
conformed to the Guidelines for Animal Experiments and were approved by 
the Animal Research Committee of Kyoto University. 
2.2. Audiogenic seizure induction 
Lgi1L385R/+ rats and WTs were divided into 3 groups (Fig. 1A). Group A (8 
Lgi1L385R/+ rats and 6 WTs) received no acoustic stimuli; Group B (7 
Lgi1L385R/+ rats and 9 WTs) received an acoustic priming stimulus only (120 
dB, 10 kHz, 1 min.) at P16; Group C (7 Lgi1L385R/+ rats and 7 WTs) received 
both the priming stimulus and an acoustic test stimulus (120 dB, 10 kHz, 5 
min.) at 8 weeks of age (Fig. 1A), as previously described (Baulac et al., 
2012). 
2.3. EEG during seizures 
Cortical EEG was recorded from group C rats, with simultaneous 
behavioral observation. At 6 weeks of age, electrodes were positioned 
stereotaxically (Paxinos and Watson, 2007; Hanaya et al., 2012) under 
sodium pentobarbital anesthesia (40 mg/kg i.p., Somnopentyl®, Kyoritsu 
Seiyaku Corp., Tokyo, Japan). A stainless steel bipolar electrode (0.2 mm 
diameter) was implanted in all rats in the left lateral temporal lobe (–3.96 
mm posterior from bregma (P); 6.0 mm lateral from midline (L); –5.0 mm 
depth from brain surface (D)). Then, in six rats (three per genotype), a screw 
electrode (1 mm diameter) was placed in the left frontal lobe (P, -3.8; L, 2.0; D, 
-2.2). In three other Lgi1L385R/+ rats and two WTs, a second 0.2 mm bipolar 
electrode was implanted in the right lateral temporal lobe (P, –3.96; L, –6.0; 
D, –5.0). A reference electrode was fixed on the frontal cranium. Electrode 
positions are shown in Fig. 1C. The rats recovered for 2 weeks and EEG was 
recorded at 8 weeks (Baulac et al., 2012). 
2.4. Fos immunohistochemistry 
At 8 weeks of age (groups A and B), or 2-h after the last acoustic stimulus 
(group C), rats were perfused with 4% paraformaldehyde and Fos 
immunohistochemistry was performed as described by Ohno et al. (2009). 
Fos-IR nuclei were counted within a 350-µm × 350-µm grid laid over each of 
the brain regions illustrated in Fig. 2A by observers who were blinded to 
seizure activity. 
2.5. Microarrays 
Lateral temporal lobes were dissected from rats in groups B and C (n=3 per 
group). Brain tissues were transported on ice immediately after surgery and 
pulverized in 1 ml of Isogen reagent (Nippon Gene, Tokyo, Japan) using a 
tissue homogenizer. Fifty milligrams of tissue from the temporal lobes were 
used for RNA isolation. Total RNA was then extracted and purified using an 
RNase free kit containing chloroform, isopropanol, and ethanol according to 
the protocol of Isogen reagent. The quantity and quality of the RNA was 
determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo 
Scientific, Wilmington, DE, USA). One-color hybridization was performed 
using the SurePrint G3 Rat GE 8 × 60 K microarray (Agilent Technologies, 
Santa Clara, CA, USA) and data were generated using Agilent Feature 
Extraction software. Scatter plot clustering, and pathway analysis were 
conducted using GeneSpringGX software (Agilent Technologies). 
2.6. Statistical analysis 
 All values are expressed as mean ± SEM. Statistical significance at p < 0.05 
was determined by Student’s t-test.  
 
3. Results and discussion 
3.1 Audiogenic seizures and EEG characteristics 
The auditory test stimulus induced wild running behavior, typical of AGS, 
in all WT and Lgi1L385R/+ rats in group C (n=7 per group). In addition, all 
Lgi1L385R/+ rats had GTCS immediately after wild running (Fig. 1B and 
Supplementary video). Acoustic priming stimuli at P16 were critical for 
inducing AGS in Lgi1L385R/+ rats, as we reported previously (Baulac et al., 
2012). EEG in Lgi1L385R/+ rats showed 5–7 Hz slow rhythmic activity and 
then rhythmic spikes (Fig. 1D). 
An onset of AGS at 8 weeks in rats is comparable to the age of onset of 
ADLTE in humans (Michelucci et al., 2009). The developing auditory system 
of rats at P16 is plastic enough to be affected by environmental acoustic 
stimuli (Romijn et al., 1991; Mashimo et al., 2010). This suggests that 
newborn babies with a mutation in LGI1 may benefit from an environment 
with minimal acoustic stimuli until the sensitive neurodevelopmental phase 
has passed. Indeed, considering the incomplete penetrance of ADLTE in 
families (Ottman et al., 1995; Ottman et al., 2004; Michelucci et al., 2009), 
environmental factors such as acoustic stimuli before neurological 
maturation may be essential for evoking seizures in later life. 
No interictal EEG abnormality was observed in WT or Lgi1L385R/+ rats 
without acoustic stimulation. Furthermore, no notable time-lags in the onset 
of wild running behavior or GTCS were observed between the two 
hemispheres (Fig. 1E), or between the left lateral temporal lobe and left 
frontal lobe (Fig. 1F). In patients with ADLTE, however, the left lateral 
temporal lobe is preferentially affected. The nature of these differences is 
unclear; however, the existence of intrinsic interhemispheric differences 
remains debated (Cain et al., 1989; Vinogradova, 2010). In addition, the 
brain may have functional asymmetry, observable in the lateralization of 
reinforcement sensitivity in rats (Glick and Ross, 1981), indicating that both 
congenital and environmental factors might contribute to the hemispheric 
asymmetry in epileptogenesis. 
3.2 Fos immunohistochemistry after AGS 
After AGS (group C), Lgi1L385R/+ rats had a marked elevation of Fos-IR cells 
compared with those that received a priming stimulus only (group B), in 
several structures including the temporal lobe, thalamus and hypothalamus 
(Fig. 2C). Elevated Fos immunoreactivity in group C WT rats was observed 
only in the posterior hypothalamus and CA2 field of the hippocampus (Fig. 
2D). 
Fos immunoreactivity was not different between Lgi1L385R/+ and WT rats 
without acoustic stimulation (group A) in any brain region except the 
posteromedial cortical amygdaloid nucleus (Fig. 2B). Similarly, Lgi1L385R/+ 
rats in groups A and B showed no differences in Fos-IR cell numbers except a 
reduction of Fos activation in the cingulate cortex and dorsomedial striatum 
after the priming stimulus (Fig. 2E). In WT rats, however, markedly more 
Fos-IR cells were observed in group B in numerous subregions in the cortex, 
hippocampus, amygdala, thalamus, and hypothalamus, compared with 
group A (Fig. 2F).  
The excited areas in Lgi1L385R/+ rats after GTCS, such as the temporal lobe 
and thalamus, correspond to the acoustic neural network (Valjakka et al., 
2000). These areas are also consistent with the epileptic focus in human 
ADLTE patients, whereas previous studies indicate that seizures initiate in 
the hippocampus in Lgi1 knockout mice (Fukata et al., 2010; Baulac et al., 
2012). LGI1 protein is abundant in the human temporal neocortex, especially 
in the lateral temporal lobe (Furlan et al., 2006), while mouse Lgi1 is highly 
expressed in the dentate gyrus and CA3 field of the hippocampus (Senechal 
et al., 2005; Herranz-Perez et al., 2010). While spontaneous seizures 
originate in the hippocampus in mice and rats, AGS in rats may originate in 
the acoustic neural network, as is seen in human ADLTE patients. 
 
3.3 Gene expression in lateral temporal lobe after AGS 
After exclusion of unnamed genes, and genes with less than a twofold 
difference in expression, a total of 447 genes with differential expression 
between groups B and C were identified in Lgi1L385R/+ rats (Fig. 3A) and in 
WTs (Fig. 3B). In Lgi1L385R/+ rats, 99 genes were upregulated and 109 were 
downregulated in group C compared with group B, while in WTs 85 genes 
were upregulated and 200 were downregulated. A summary of differentially 
expressed genes is provided in Fig. 3C, and fold-change values for all 447 
genes are provided in Supplementary Table S1. 
Some of the differentially expressed genes have previously been associated 
with epilepsy (Supplementary Table S2 and Fig. 3C). Adora2a and Rgs9 
interact with Lgi1, according to the STRING database; these interactions 
might affect epileptogenesis in Lgi1L385R/+ rats. Egr2 and c-Fos are both 
activity-dependent genes whose expression is highly correlated with the 
amplitude and frequency of interictal spikes (Rakhade et al., 2007). However, 
this is inconsistent with the downregulation of Egr2 in Lgi1L385R/+ rats 
following the acoustic test stimulus. Considering the apparent inhibition of 
Fos activation in Lgi1L385R/+ rats after the acoustic priming stimulus, 
suppression of c-Fos and Egr2 might be related to epileptogenesis in 
Lgi1L385R/+ rats. Kcnj13 was previously reported as a candidate gene for 
epileptogenicity (Winden et al., 2011); however, its expression was 
downregulated after the test stimulus in Lgi1L385R/+ rats. Conversely, it was 
reported that mice lacking the Stam gene had a loss of hippocampal CA3 
pyramidal neurons (Yamada et al., 2001), whereas the expression of Stam 
was upregulated in Lgi1 mutant rats after the test stimulus. These results 
indicate that the change in expression of these genes was due to the response 
after GTCS rather than to the epileptic susceptibility of Lgi1 mutant rats. In 
addition, genes associated with inflammation, such as interleukin 1 beta 
(Il1b) and chemokine (C-C motif) ligand 3 (Ccl3), were particularly 
upregulated after the audiogenic seizures.  
The Lgi1 gene itself and 16 genes previously reported to be associated with 
it showed no significant differences in mRNA expression (Table 1). This is 
consistent with the idea that the phenotype of Lgi1L385R/+ rats is derived from 
the loss of functional LGI1 protein rather than that of mRNA (Baulac et al., 
2012). Most patients with ADLTE have mutations in the LGI1 gene that 
impair protein secretion (Senechal et al., 2005; Michelucci et al., 2009; Nobile 
et al., 2009; Di Bonaventura et al., 2011). Recently, Striano et al. (2011) 
reported a family with ADLTE with a novel LGI1 mutation (R407C) that did 
not disturb LGI extracellular protein secretion; the R407C LGI1 mutation, 
however, disrupts interactions with its target proteins (Striano et al., 2011). 
In the case of Lgi1L385R/+ rats, we previously demonstrated that L385R-LGI1 
protein was unstable and appeared to have a short half-life, leading to loss of 
function (Baulac et al., 2012).  
 
4. Conclusions 
Neurons in the lateral temporal lobe, in particular the auditory cortex, of 
Lgi1L385R/+ rats were significantly activated by acoustic stimuli. The 
expression levels of a subset of genes which may be involved in epilepsy were 
significantly changed uniquely in Lgi1L385R/+ rats after AGS, while those of 
Lgi1 itself and associated genes were not altered. Our study indicates the 
existence of an unknown seizure mechanism in the AGS rats and highlights 
the utility of Lgi1L385R/+ rats as an animal model of ADLTE. 
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Figure Legends 
Fig. 1. EEG during audiogenic seizures. (A) Lgi1L385R/+ rats and WTs are 
divided into 3 groups: A (no auditory stimulation), B (acoustic priming 
stimulus only), and C (acoustic priming and test stimuli). (B) Behavior 
following acoustic test stimulation in group C rats. All Lgi1L385R/+ rats 
showed wild running behavior and GTCS while all WT rats showed only wild 
running. (C) Placement of electrodes. Red asterisks, bipolar electrode in the 
left lateral temporal lobe; monopolar electrode in the right lateral temporal 
lobe or left frontal lobe. Blue asterisk: indifferent electrode in right frontal 
area of cranium. (D) EEG recording during audiogenic seizure. Slow (5–7 Hz) 
rhythmic activity was followed by rhythmic spikes. (E, F) EEG of Lgi1L385R/+ 
rat with wild running and GTCS. There was no notable time lag between 
temporal lobes (E) or between the left lateral temporal lobe and the left 
frontal lobe (F) in onset of either wild running (blue arrow) or GTCS (purple 
arrow). GTCS, generalized tonic-clonic seizures. 
 
Fig. 2. Fos immunohistochemistry. Results presented are from the right 
hemisphere. (A) Brain regions (black squares) selected for quantitative 
analysis of Fos-IR cells; cited from Ohno et al. (2009). Anteroposterior 
coordinates (distance from Bregma) are shown above each brain section. (B) 
Fos-IR cell numbers in WT vs. Lgi1L385R/+ rats in group A. (C) Fos-IR cell 
numbers in Lgi1L385R/+ rats, group B vs. group C. Results demonstrate a 
marked general elevation of Fos-IR cell numbers in group C compared to 
group B, as well as significant increases in AuC, LHb, Pt, AM, AH, PH, DMH, 
Pir2 and CA3. (D) Fos-IR cell numbers in WT rats, group B vs. group C. Fos 
immunoreactivity is similar in most subregions except CA2 and PH, where it 
is significantly higher in group C. (E) Fos-IR cell numbers in Lgi1L385R/+ rats, 
group A vs. group B. Results demonstrate reduced Fos immunoreactivity in 
CgC and dmST after priming stimulation. (F) Fos-IR in WT rats, group A vs. 
group B. A general elevation in Fos-IR cell numbers is seen in group B, with 
significant differences in mPFC, MC3, SC2, SC3, Pir2, PRh-Ent, CA2, PMCo, 
PT, VM and PH. Data are expressed as mean ± S.E.M. Student t-test, *p < 
0.05; **p < 0.01. AcC, nucleus accumbens core; AcS, nucleus accumbens shell 
AH, anterior hypothalamus; AIC, agranular insular cortex; AM, 
anteromedial thalamus; AuC, auditory cortex; BMA, basomedial amygdaloid 
nucleus; Cg, cingulate cortex; CM, centromedial thalamus; DG, dentate 
gyrus of the hippocampus; dlST, dorsolateral striatum; DMH, dorsomedial 
hypothalamus; dmST, dorsomedial striatum; Fos-IR, Fos-like 
immunoreactive; GP, globus pallidus; LaVM, lateral amygdaloid nucleus 
ventromedialis; LHb, lateral habenula; LS, lateral septum; MC, motor 
cortex; mPFC, medial prefrontal cortex; PH, posterior hypothalamus; Pir, 
piriform cortex; PMCo, posteromedial cortical amygdaloid nucleus; PRh-Ent, 
perirhinal-entorhinal cortex; PT, paratenial thalamus; SC, sensory cortex; 
VM, ventromedial thalamus.  
 
Fig. 3. Microarray analysis.  
Scatter plot analysis of gene expression in (A) WT and (B) Lgi1L385R/+ rats in 
group B vs. group C. Upregulated genes are identifiable as a leftward shift 
from the correlation line, and downregulated genes as a rightward shift. (C) 
Genes were divided into 8 groups by patterns of expression changes in group 
C compared with group B. ↑, upregulated gene expression in group C 
compared with group B (≥ twofold); ↓, downregulated gene expression in 
group C compared with group B (≤ half); →, gene expression in group C 
within 0.5–2 times that in group B; Lgi1, Lgi1L385R/+ rats; F344, WT rats; 
*Epilepsy-related genes (see Table S2). 
 
Table 1. Expression of Lgi1 and 16 related genes. No significant differences 
were seen in mRNA expression between genotype or acoustic stimulus group. 
The gScale signal value of LGI1 and related genes are given. 
 
 
Table S1 Genes whose mRNA expression doubled or halved in secondary 
acoustic stimuli. 
 
Table S2. Examples of epilepsy-related genes with differential expression 
between group B (priming stimulation only) and group C (priming 
stimulation and test stimulation-induced audiogenic seizures). Genes were 
found using PubMed, Sciverse Scopus and Web of Science, with the search 




Acoustic test stimulation 
(120 dB, 10 kHz, 1 min., no interval)
Group B
Group C
Acoustic priming stimulation 
(120 dB, 10 kHz, 5 min., no interval)
(8 Lgi1L385R/+ rats and 6 WTs)
(7 Lgi1L385R/+ rats and 9 WTs)




wild running + GTCS
n(%)
WTs (n=7) 7 (100%) 0 (0%) 
Lgi1L385R/+ rats (n=7) 0 (0%) 7 (100%) 
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group C vs. group B
F344 control rats
group C vs. group B
Lgi1L385R/+ rats
↑ 131 genes, ↓ 158 genes
F344 control rats




↑ 99 genes, ↓ 109 genes
F344 control rats




Table 1. Expression of Lgi1 and 16 related genes. No significant differences were seen in 
mRNA expression between genotype or acoustic stimulus group.  
Gene symbol Gene name 
gScale signal 
Lgi1 mutant WT 
Group B Group C Group B Group C 
Lgi1 leucine-rich, glioma inactivated 1 1047.6  1033.8  1123.0  1075.7  
Lgi2 
leucine-rich repeat LGI family, 
member 2 
381.1  298.9  370.9  340.9  
Lgi3 
leucine-rich repeat LGI family, 
member 3 
28313.2  19155.6  26228.8  25912.3  
Lgi4 
leucine-rich repeat LGI family, 
member 4 
5345.1  4658.4  5206.1  5781.8  
ADAM11 
ADAM metallopeptidase domain 
11 
430.8  404.7  387.3  421.2  
ADAM22 
ADAM metallopeptidase domain 
22 
654.0  583.6  625.2  682.4  
ADAM23 
ADAM metallopeptidase domain 
23 
465.8  473.2  456.0  486.9  
KCNA1 
potassium voltage-gated channel, 
shaker-related subfamily, 
member 1 
17030.6  13007.3  16030.4  16952.0  
KCNA4 
potassium voltage-gated channel, 
shaker-related subfamily, 
member 4 
536.9  571.7  565.0  506.7  
KCNAB1 
potassium voltage-gated channel, 
shaker-related subfamily, beta 
member 1 
3444.3  3663.0  3486.2  3907.2  
PDYN prodynorphin 3393.1  3385.6  3277.4  3112.7  
GRIA2 
glutamate receptor, ionotropic, 
AMPA 2 
3345.2  3932.1  3636.1  3512.4  
GRIA3 
glutamate receptor, ionotropic, 
AMPA 3 
24599.7  28802.5  25026.8  23864.9  
GABBR1 
gamma-aminobutyric acid 
(GABA) B receptor, 1 
3908.2  4146.3  4031.5  4063.9  
RAF1 
v-raf-1 murine leukemia viral 
oncogene homolog 1 
1724.7  1769.1  1752.3  1747.0  
AKT1 
v-akt murine thymoma viral 
oncogene homolog 1 
2148.3  2140.0  2286.7  2264.4  
RTN4r reticulon 4 receptor 4808.4  5395.3  5311.4  5100.4  




(C vs B) 
WT 







A_64_P086244 4.82 1.10 Tll2 
Rattus norvegicus tolloid-like 2 (Tll2), 
mRNA [NM_001191898] 
chr1 tolloid-like 2 
A_64_P002285 2.10 1.09 
LOC6790
87 
PREDICTED: Rattus norvegicus similar 
to swan (LOC679087), mRNA 
[XM_001054639] 
chr5 similar to swan 
A_64_P080370 1.84 2.09 Vom2r73 
Rattus norvegicus vomeronasal 2 
receptor, 73 (Vom2r73), mRNA 
[NM_001099486] 
chr14 vomeronasal 2 receptor, 73 
A_64_P112305 1.49 1.05 
LOC4978
60 
Rattus norvegicus similar to RIKEN 
cDNA 4930517K11 (LOC497860), mRNA 
[NM_001195471] 
chr10 
similar to RIKEN cDNA 
4930517K11 
A_64_P008166 1.43 2.02 Slc19a3 
Rattus norvegicus solute carrier family 
19, member 3 (Slc19a3), mRNA 
[NM_001108228] 
chr9 
solute carrier family 19, 
member 3 
A_44_P1055780 1.28 1.87 S100a8 
Rattus norvegicus S100 calcium binding 
protein A8 (S100a8), mRNA [NM_053822] 
chr2 
S100 calcium binding protein 
A8 
A_64_P065037 1.12 2.37 Plagl2 







A_64_P060038 1.07 1.62 
Hmgb1-
ps2 
Rattus norvegicus high mobility group box 
1, pseudogene 2 (Hmgb1-ps2), non-coding 
RNA [NR_024023] 
chr17 
high mobility group box 1, 
pseudogene 2 
A_44_P659117 1.07 1.14 Zic4 
Rattus norvegicus Zic family member 4 
(Zic4), mRNA [NM_001108176] 
chr8 Zic family member 4 
A_44_P605002 -4.49 -1.17 Slc45a4 
PREDICTED: Rattus norvegicus solute 
carrier family 45, member 4, transcript 
variant 2 (Slc45a4), mRNA 
[XM_002726935] 
chr7 
solute carrier family 45, 
member 4 
A_64_P122489 -2.02 -3.03 Hdc 
Rattus norvegicus histidine decarboxylase 
(Hdc), mRNA [NM_017016] 
chr3 histidine decarboxylase 
A_64_P098515 -1.64 -2.57 
LOC6808
85 
Rattus norvegicus hypothetical protein 





A_44_P177857 -1.39 -3.33 Ttll2 
Rattus norvegicus tubulin tyrosine ligase-
like family, member 2 (Ttll2), mRNA 
[NM_001169136] 
chr1 
tubulin tyrosine ligase-like 
family, member 2 
A_64_P037883 -1.35 -1.91 Tctex1d4 
PREDICTED: Rattus norvegicus Tctex1 
domain containing 4 (Tctex1d4), mRNA 
[XM_001071721] 
chr5 Tctex1 domain containing 4 
A_64_P072900 -1.15 -1.74 Astl 
Rattus norvegicus astacin-like 






A_64_P147569 -1.14 -2.58 
RGD1563
200 
Rattus norvegicus similar to CDNA 
sequence BC048502 (RGD1563200), 
mRNA [NM_001109288] 
chr7 
similar to CDNA sequence 
BC048502 







similar to Solute carrier 
family 6 (neurotransmitter 
transporter), member 20 
A_64_P054112 -1.11 -1.96 T 
Rattus norvegicus T, brachyury homolog 
(mouse) (T), mRNA [NM_001106209] 
chr1 
T, brachyury homolog 
(mouse) 
A_43_P15474 -1.11 -1.22 Spef2 
Rattus norvegicus sperm flagellar 2 
(Spef2), mRNA [NM_022620] 
chr2 sperm flagellar 2 
A_64_P146444 -1.09 -2.85  
Rattus norvegicus similar to Spindlin-like 
protein 2 (SPIN-2) (LOC301882), mRNA 
[XM_229364] 
chr16 
similar to Spindlin-like 
protein 2 (SPIN-2) 
A_44_P412647 -1.06 -1.42 Gins2 
Rattus norvegicus GINS complex subunit 
2 (Psf2 homolog) (Gins2), mRNA 
[NM_001106190] 
chr19 





PREDICTED: Rattus norvegicus similar 
to expressed sequence AU021034 
(RGD1560137), miscRNA [XR_008828] 
chr15 





Rattus norvegicus nuclear receptor 
subfamily 4, group A, member 3 (Nr4a3), 
transcript variant 1, mRNA [NM_031628] 
chr5 
nuclear receptor subfamily 4, 










Rattus norvegicus ubiquitin-conjugating 








Rattus norvegicus neurotrophic tyrosine 
kinase, receptor, type 1 (Ntrk1), mRNA 
[NM_021589] 
chr2 
neurotrophic tyrosine kinase, 




Rattus norvegicus LIM homeobox 8 
(Lhx8), mRNA [NM_001012219] 




Rattus norvegicus family with sequence 
similarity 178, member B (Fam178b), 
mRNA [NM_001122658] 
chr9 
family with sequence 




Rattus norvegicus regulator of G-protein 
signaling 9 (Rgs9), mRNA [NM_019224] 
chr10 





Rattus norvegicus sperm associated 
antigen 6-like (Spag6l), mRNA 
[NM_001106125] 
chr17 





Rattus norvegicus similar to Y-LINKED 
TESTIS-SPECIFIC PROTEIN 
(LOC367436), mRNA [XM_346138] 
chrUn 





Rattus norvegicus adenosine A2a receptor 
(Adora2a), mRNA [NM_053294] 




Rattus norvegicus troponin I type 3 
(cardiac) (Tnni3), mRNA [NM_017144] 




PREDICTED: Rattus norvegicus similar 
to cis-Golgi matrix protein GM130, 
transcript variant 2 (LOC686907), mRNA 
[XM_001076221] 
chr3 














Rattus norvegicus sperm acrosome 
associated 5 (Spaca5), mRNA 
[NM_001108058] 






PREDICTED: Rattus norvegicus similar 
to Prostatic steroid-binding protein C1 
chain precursor (Prostatein peptide C1) 
(LOC686388), mRNA [XM_001073908] 
chr1 
similar to Prostatic steroid-





PREDICTED: Rattus norvegicus similar 
to testis nuclear RNA-binding protein 
(LOC691275), mRNA [XM_002725395] 
chr19 







Rattus norvegicus LRRGT00186 





Rattus norvegicus olfactory receptor 670 
(Olr670), mRNA [NM_001000633] 
chr3 






Rattus norvegicus olfactory receptor 250 
(Olr250), mRNA [NM_001001037] 




Rattus norvegicus family with sequence 
similarity 109, member B (Fam109b), 
mRNA [NM_001130511] 
chr7 
family with sequence 






Rattus norvegicus similar to chromosome 
18 open reading frame 54 (LOC361346), 
mRNA [NM_001017462] 
chr18 
similar to chromosome 18 




Rattus norvegicus testicular serine 
protease 2 (Tesp2), mRNA 
[NM_001108209] 






Rattus norvegicus similar to netrin 4 
(RGD1565947), mRNA [NM_001106780] 






PREDICTED: Rattus norvegicus similar 
to basic transcription factor 3 
(RGD1561766), miscRNA [XR_009374] 
chr3 





Rattus norvegicus Ac1-283 mRNA, 





Rattus norvegicus similar to 
Translationally controlled tumor protein 
(TCTP) (p23) (21 kDa polypeptide) (p21) 
(Lens epithelial protein) (LOC289930), 
mRNA [XM_223826] 
chr15 
similar to Translationally 
controlled tumor protein 
(TCTP) (p23) (21 kDa 





Rattus norvegicus coiled-coil domain 
containing 152 (Ccdc152), mRNA 
[NM_001191959] 
chr2 





Rattus norvegicus solute carrier family 1 
(glutamate transporter), member 7 
(Slc1a7), mRNA [NM_001108973] 
chr5 








Rattus norvegicus LRRGT00178 





AN1-type zinc finger and ubiquitin 










Rattus norvegicus zinc finger CCCH type 
containing 12D (Zc3h12d), mRNA 
[NM_001107469] 
chr1 















Rattus norvegicus testis expressed 28 
(Tex28), mRNA [NM_001191103] 





















Rattus norvegicus solute carrier family 7 
(cationic amino acid transporter, y+ 
system), member 15 (Slc7a15), mRNA 
[NM_001106714] 
chr6 
solute carrier family 7 
(cationic amino acid 














Rattus norvegicus serine/threonine kinase 
32A (Stk32a), mRNA [NM_001191894] 






PREDICTED: Rattus norvegicus 






Rattus norvegicus tubulin, gamma 
complex associated protein 5 (Tubgcp5), 
mRNA [NM_001107516] 
chr1 
tubulin, gamma complex 




O16480_CAEEL (O16480) Serpentine 
receptor, class t protein 8, partial (5%) 
[TC627292] 
chr15 





Rattus norvegicus palate, lung and nasal 
epithelium associated (Plunc), mRNA 
[NM_172031] 
chr3 







Rattus norvegicus similar to Mediator of 
RNA polymerase II transcription, subunit 
9 homolog (RGD1563669), mRNA 
[NM_001127302] 
chr10 
similar to Mediator of RNA 
polymerase II transcription, 




Rattus norvegicus leucine rich repeat 
containing 10B (Lrrc10b), mRNA 
[NM_001107577] 
chr1 





Rattus norvegicus regulator of calcineurin 
1 (Rcan1), mRNA [NM_153724] 




Rattus norvegicus zinc finger protein 469 
(Zfp469), mRNA [NM_001107123] 
chr12 





Rattus norvegicus similar to cytoplasmic 
beta-actin (LOC298169), mRNA 
[XM_233107] 
chrX 





PREDICTED: Rattus norvegicus 
phosphatidylethanolamine binding 












zinc finger with KRAB and 











PREDICTED: Rattus norvegicus similar 
to hypothetical protein 4932411N23 
(RGD1561151), mRNA [XM_001066024] 
chrX 





Rattus norvegicus S100 calcium binding 
protein A9 (S100a9), mRNA [NM_053587] 
chr2 





Rattus norvegicus insulin-like growth 
factor binding protein-like 1 (Igfbpl1), 
mRNA [NM_001108972] 
chr5 
insulin-like growth factor 




Rattus norvegicus alpha 1,3-










Rattus norvegicus similar to hypothetical 
protein FLJ20010 (RGD1563941), mRNA 
[NM_001109293] 
chr8 





Rattus norvegicus epithelial splicing 
regulatory protein 1 (Esrp1), mRNA 
[NM_001127564] 
chr5 





Rattus norvegicus solute carrier family 12 
(sodium/chloride transporters), member 3 
(Slc12a3), mRNA [NM_019345] 
chr19 
solute carrier family 12 
(sodium/chloride 




PREDICTED: Rattus norvegicus G 
protein-coupled receptor 152 (Gpr152), 
mRNA [XM_002725764] 
chr1 





Rattus norvegicus retinoid X receptor 
gamma (Rxrg), mRNA [NM_031765] 
















Rattus norvegicus similar to RIKEN 
cDNA 2610002M06 (RGD1566265), 
mRNA [NM_001134589] 
chrX 





Rattus norvegicus dopamine receptor D2 
(Drd2), mRNA [NM_012547] 




Rattus norvegicus napsin A aspartic 
peptidase (Napsa), mRNA [NM_031670] 




Rattus norvegicus myosin, heavy chain 2, 
skeletal muscle, adult (Myh2), mRNA 
[NM_001135157] 
chr10 
myosin, heavy chain 2, 




Rattus norvegicus heparan sulfate 6-O-










PREDICTED: Rattus norvegicus similar 
to developmental pluripotency-associated 
2 (LOC683282), mRNA [XM_001065240] 
chr11 





Rattus norvegicus zinc finger protein 278 
(Zfp278), mRNA [NM_001107231] 












Rattus norvegicus olfactory receptor 1688 
(Olr1688), mRNA [NM_001000275] 




Rattus norvegicus nuclear assembly factor 
1 homolog (S. cerevisiae) (Naf1), mRNA 
[NM_001024772] 
chr16 
nuclear assembly factor 1 




Rattus norvegicus signal transducing 
adaptor molecule (SH3 domain and ITAM 
motif) 1 (Stam), mRNA [NM_001109121] 
chr17 
signal transducing adaptor 
molecule (SH3 domain and 




C5AR_RABIT (Q9TUE1) C5a 
anaphylatoxin chemotactic receptor (C5a-
R) (C5aR) (CD88 antigen) (Fragment), 
partial (7%) [TC623897] 
chr11 
C5a anaphylatoxin 




PREDICTED: Rattus norvegicus myosin, 
heavy chain 13, skeletal muscle (Myh13), 
mRNA [XM_001078857] 
chr10 





Rattus norvegicus FtsJ methyltransferase 








Rattus norvegicus zinc finger and BTB 
domain containing 39 (Zbtb39), mRNA 
[NM_001130537] 
chr7 
zinc finger and BTB domain 
containing 39 
   
<±1.00 












Rattus norvegicus similar to RIKEN 
cDNA A930018P22 (RGD1563222), 
mRNA [NM_001108585] 
chr3 











Rattus norvegicus zinc finger protein 563 
(Zfp563), mRNA [NM_001134561] 
chr7 







PREDICTED: Rattus norvegicus similar 
to transcription factor ONECUT2 
(RGD1564677), partial mRNA 
[XM_002725360] 
chr18 





Rattus norvegicus galectin-related inter-








Rattus norvegicus keratin 15 (Krt15), 
mRNA [NM_001004022] 






Rattus norvegicus hypothetical protein 








Rattus norvegicus proteinase 3 (Prtn3), 
mRNA [NM_001024264] 




Rattus norvegicus tubby-like protein 2 
(Tulp2), mRNA [NM_001012168] 






Rattus norvegicus hypothetical protein 








Rattus norvegicus oligodendrocytic myelin 









Rattus norvegicus coiled-coil domain 
containing 135 (Ccdc135), mRNA 
[NM_001106169] 
chr19 





Rattus norvegicus apolipoprotein D 
(Apod), mRNA [NM_012777] 




Rattus norvegicus solute carrier family 4 
(anion exchanger), member 1 (Slc4a1), 
mRNA [NM_012651] 
chr10 
solute carrier family 4 (anion 




Rattus norvegicus similar to hypothetical 
protein MGC29761 (RGD1306233), 
mRNA [NM_001106564] 
chr3 





Rattus norvegicus immediate early 
response 2 (Ier2), mRNA 
[NM_001009541] 




Rattus norvegicus ermin, ERM-like 
protein (Ermn), mRNA [NM_001008311] 




Rattus norvegicus paired box 4 (Pax4), 
mRNA [NM_031799] 




Rattus norvegicus pleckstrin homology 
domain containing, family F (with FYVE 
domain) member 1 (Plekhf1), mRNA 
[NM_001013148] 
chr1 
pleckstrin homology domain 
containing, family F (with 




Rattus norvegicus SLIT and NTRK-like 
family, member 6 (Slitrk6), mRNA 
[NM_001106057] 
chr15 





Rattus norvegicus phosphatidic acid 








Rattus norvegicus nuclear factor, 
interleukin 3 regulated (Nfil3), mRNA 
[NM_053727] 
chr17 





Rattus norvegicus inscuteable homolog 








Rattus norvegicus DnaJ (Hsp40) homolog, 
subfamily C, member 28 (Dnajc28), 
mRNA [NM_001014124] 
chr11 
DnaJ (Hsp40) homolog, 




Rattus norvegicus chloride channel 
accessory 1 (Clca1), mRNA 
[NM_001107449] 




Rattus norvegicus hypothetical protein 








Rattus norvegicus SET and MYND 
domain containing 1 (Smyd1), mRNA 
[NM_001106595] 
chr4 





Rattus norvegicus protein phosphatase 1, 
regulatory (inhibitor) subunit 14A 
(Ppp1r14a), mRNA [NM_130403] 
chr1 
protein phosphatase 1, 





Rattus norvegicus connective tissue 
growth factor (Ctgf), mRNA [NM_022266] 
chr1 





Rattus norvegicus similar to glutamine 
repeat protein 1 (LOC365129), mRNA 
[XM_344830] 
chr1 random 





Rattus norvegicus RAS-like family 11 
member A (Rasl11a), mRNA 
[NM_001002829] 
chr12 





Rattus norvegicus hypothetical protein 








Rattus norvegicus myelin oligodendrocyte 







Rattus norvegicus tribbles homolog 1 
(Drosophila) (Trib1), mRNA [NM_023985] 
chr7 















Rattus norvegicus serum/glucocorticoid 








Rattus norvegicus neurotrophic tyrosine 
kinase, receptor, type 2 (Ntrk2), 
transcript variant 3, mRNA 
[NM_001163169] 
chr17 
neurotrophic tyrosine kinase, 




Rattus norvegicus gap junction protein, 
gamma 2 (Gjc2), mRNA [NM_001100784] 
chr10 





Rattus norvegicus polo-like kinase 3 
(Plk3), mRNA [NM_022187] 




Rattus norvegicus transmembrane 
protein 116 (Tmem116), mRNA 
[NM_001159625] 




Rattus norvegicus zinc finger protein 438 
(Zfp438), mRNA [NM_001107358] 




Rattus norvegicus hypothetical protein 








Rattus norvegicus alkylglycerol 
monooxygenase (Agmo), mRNA 
[NM_001135899] 




Rattus norvegicus cysteine-serine-rich 








Rattus norvegicus v-erb-b2 erythroblastic 
leukemia viral oncogene homolog 3 
(avian) (Erbb3), mRNA [NM_017218] 
chr7 
v-erb-b2 erythroblastic 
leukemia viral oncogene 




Rattus norvegicus tubulin polymerization-
promoting protein family member 3 
(Tppp3), mRNA [NM_001009639] 
chr19 
tubulin polymerization-





Rattus norvegicus IQ motif containing 
GTPase activating protein 3 (Iqgap3), 
mRNA [NM_001191709] 
chr2 
IQ motif containing GTPase 




Rattus norvegicus myelin-associated 








Rattus norvegicus triggering receptor 
expressed on myeloid cells-like 1 (Treml1), 
mRNA [NM_001192001] 
chr9 
triggering receptor expressed 




Rattus norvegicus leukocyte 
immunoglobulin-like receptor, subfamily 
B (with TM and ITIM domains), member 
3-like (Lilrb3l), mRNA [NM_001037357] 
chr1 
leukocyte immunoglobulin-
like receptor, subfamily B 
(with TM and ITIM 




Rattus norvegicus ectonucleotide 
pyrophosphatase/phosphodiesterase 6 








Rattus norvegicus solute carrier family 
45, member 3 (Slc45a3), mRNA 
[NM_001135868] 
chr13 





Rattus norvegicus regulator of G-protein 
signaling 18 (Rgs18), mRNA 
[NM_001047084] 
chr13 





Rattus norvegicus NK6 homeobox 2 
(Nkx6-2), mRNA [NM_001107558] 




Rattus norvegicus family with sequence 
similarity 83, member F (Fam83f), mRNA 
[NM_001130502] 
chr7 
family with sequence 




Rattus norvegicus C1q and tumor necrosis 
factor related protein 9 (C1qtnf9), mRNA 
[NM_001191891] 
chr15 
C1q and tumor necrosis 













Rattus norvegicus fatty acid 2-
hydroxylase (Fa2h), mRNA 
[NM_001135583] 




PREDICTED: Rattus norvegicus titin 





Rattus norvegicus retinal G protein 
coupled receptor (Rgr), mRNA 
[NM_001107299] 
chr16 





PREDICTED: Rattus norvegicus 
diaphanous homolog 2 (Drosophila) 
(Diaph2), mRNA [XM_001066898] 
chrX 





PREDICTED: Rattus norvegicus 
hypothetical protein LOC685249 







Rattus norvegicus cytochrome P450, 
family 11, subfamily a, polypeptide 1 
(Cyp11a1), nuclear gene encoding 
mitochondrial protein, mRNA 
[NM_017286] 
chr8 
cytochrome P450, family 11, 




Rattus norvegicus phosphatidylinositol 








Rattus norvegicus leucine rich repeat 
containing 36 (Lrrc36), mRNA 
[NM_001004088] 
chr19 





Rattus norvegicus DNA-damage-inducible 







Rattus norvegicus purinergic receptor 
P2Y, G-protein coupled, 2 (P2ry2), mRNA 
[NM_017255] 
chr1 
purinergic receptor P2Y, G-










Rattus norvegicus purinergic receptor 
P2X, ligand-gated ion channel, 6 (P2rx6), 
mRNA [NM_012721] 
chr11 
purinergic receptor P2X, 




Rattus norvegicus ATP-binding cassette, 









Rattus norvegicus similar to hypothetical 
protein MGC34760 (RGD1359349), 
mRNA [NM_001007738] 
chr1 





Rattus norvegicus coiled-coil domain 
containing 153 (Ccdc153), mRNA 
[NM_001013953] 
chr8 





Rattus norvegicus BTG family, member 2 
(Btg2), mRNA [NM_017259] 













Rattus norvegicus ADAM 
metallopeptidase with thrombospondin 









Rattus norvegicus claudin 11 (Cldn11), 
mRNA [NM_053457] 




Rattus norvegicus olfactory receptor 403 
(Olr403), mRNA [NM_001000381] 




Rattus norvegicus TBC1 domain family, 
member 10C (Tbc1d10c), mRNA 
[NM_001081980] 
chr1 





Rattus norvegicus proteolipid protein 1 
(Plp1), mRNA [NM_030990] 




Rattus norvegicus CCAAT/enhancer 
binding protein (C/EBP), delta (Cebpd), 
 
CCAAT/enhancer binding 





Rattus norvegicus nerve growth factor 
receptor (TNFR superfamily, member 16) 
(Ngfr), mRNA [NM_012610] 
chr10 
nerve growth factor receptor 





Rattus norvegicus olfactory receptor 1516 
(Olr1516), mRNA [NM_001000038] 




Rattus norvegicus peripheral myelin 
protein 2 (Pmp2), mRNA 
[NM_001109514] 




Rattus norvegicus gap junction protein, 
beta 1 (Gjb1), mRNA [NM_017251] 




Rattus norvegicus B-cell CLL/lymphoma 
6, member B (Bcl6b), mRNA 
[NM_001108279] 
chr10 





Rattus norvegicus solute carrier family 31 
(copper transporters), member 1 
(Slc31a1), mRNA [NM_133600] 
chr5 






Rattus norvegicus CD40 molecule, TNF 
receptor superfamily member 5 (Cd40), 
mRNA [NM_134360] 
chr3 
CD40 molecule, TNF 





Rattus norvegicus calsequestrin 2 (cardiac 
muscle) (Casq2), nuclear gene encoding 
mitochondrial protein, mRNA 
[NM_017131] 
chr2 





Rattus norvegicus kallikrein related-







Rattus norvegicus tudor domain 
containing 5 (Tdrd5), transcript variant 2, 
mRNA [NM_001134740] 




Rattus norvegicus olfactory receptor 1108 
(Olr1108), mRNA [NM_001000993] 




PREDICTED: Rattus norvegicus 






Rattus norvegicus ubiquitin-like modifier 








Rattus norvegicus nescient helix loop 
helix 1 (Nhlh1), mRNA [NM_001105970] 




Rattus norvegicus bestrophin 1 (Best1), 
mRNA [NM_001011940] 




Rattus norvegicus salt-inducible kinase 1 
(Sik1), mRNA [NM_021693] 




Rattus norvegicus Rh blood group, D 
antigen (Rhd), mRNA [NM_022505] 




Rattus norvegicus Kruppel-like factor 2 
(lung) (Klf2), mRNA [NM_001007684] 




Rattus norvegicus radial spoke head 10 
homolog B (Chlamydomonas) (Rsph10b), 
mRNA [NM_001013867] 
chr12 





Rattus norvegicus nuclear receptor 
subfamily 4, group A, member 1 (Nr4a1), 
mRNA [NM_024388] 
chr7 
nuclear receptor subfamily 4, 




Rattus norvegicus similar to putative 









Rattus norvegicus transmembrane 
protein 88B (Tmem88b), mRNA 
[NM_001109426] 




Rattus norvegicus Kruppel-like factor 4 
(gut) (Klf4), mRNA [NM_053713] 




Ig gamma-2B chain C region 
[Source:UniProtKB/Swiss-
Prot;Acc:P20761] 





Rattus norvegicus troponin T type 1 
(skeletal, slow) (Tnnt1), mRNA 
[NM_134388] 
chr1 





Q5U2T7_RAT (Q5U2T7) Transcription 
factor B2, mitochondrial (Predicted), 
partial (21%) [TC645744] 
chr13 





Rattus norvegicus similar to novel protein 
(RGD1560672), mRNA [NM_001109073] 




Rattus norvegicus FBJ osteosarcoma 
oncogene (Fos), mRNA [NM_022197] 




Rattus norvegicus cytochrome P450, 
family 2, subfamily j, polypeptide 10 
(Cyp2j10), mRNA [NM_001134980] 
chr5 
cytochrome P450, family 2, 




Rattus norvegicus similar to Robo-1 
(LOC691277), mRNA [NM_001109633] 




PREDICTED: Rattus norvegicus 






Rattus norvegicus solute carrier family 
44, member 4 (Slc44a4), mRNA 
[NM_212541] 
chr20 





PREDICTED: Rattus norvegicus similar 
to major urinary protein 5 (LOC685577), 
miscRNA [XR_006055] 
chr5 





Rattus norvegicus jun B proto-oncogene 
(Junb), mRNA [NM_021836] 




Rattus norvegicus activity-regulated 









Rattus norvegicus forkhead box J1 
(Foxj1), mRNA [NM_053832] 




Rattus norvegicus clarin 1 (Clrn1), mRNA 
[NM_153299] 




PREDICTED: Rattus norvegicus growth 
differentiation factor 5 (Gdf5), mRNA 
[XM_001066344] 
 





Rattus norvegicus UDP-GlcNAc:betaGal 
beta-1,3-N-acetylglucosaminyltransferase 










Rattus norvegicus similar to glutamine 
repeat protein 1 (LOC365129), mRNA 
[XM_344830] 
chr1 





Rattus norvegicus dual specificity 
phosphatase 1 (Dusp1), mRNA 
[NM_053769] 
chr10 





Rattus norvegicus butyryl Coenzyme A 
synthetase 1 (Bucs1), mRNA 
[NM_001108502] 
chr1 





Rattus norvegicus paired box 9 (Pax9), 
mRNA [NM_001039539] 




Rattus norvegicus apolipoprotein L 
domain containing 1 (Apold1), mRNA 
[NM_001003403] 
chr4 





Rattus norvegicus similar to hypothetical 
protein FLJ32800 (RGD1359452), mRNA 
[NM_001013920] 
chr3 





Rattus norvegicus leucine rich repeat 
containing 34 (Lrrc34), mRNA 
[NM_001044696] 
chr2 





Rattus norvegicus similar to RIKEN 
cDNA 1700001C02 (RGD1559683), mRNA 
[NM_001109275] 
chr6 





Rattus norvegicus similar to RIKEN 
cDNA 1700009P17 (RGD1562658), mRNA 
[NM_001109075] 
chr13 





Rattus norvegicus potassium channel, 








PREDICTED: Rattus norvegicus similar 
to apoptotic chromatin condensation 
inducer 1 isoform 2 (LOC689749), mRNA 
[XM_001071871] 
chr7 
similar to apoptotic 
chromatin condensation 




Rattus norvegicus IQ motif containing G 
(Iqcg), mRNA [NM_001014230] 




Rattus norvegicus AT rich interactive 
domain 3B (Bright like) (Arid3b), mRNA 
[NM_001109001] 
chr8 
AT rich interactive domain 




Rattus norvegicus coiled-coil domain 
containing 40 (Ccdc40), mRNA 
[NM_001134688] 
chrUn 





Rattus norvegicus tumor protein p73 
(Tp73), mRNA [NM_001108696] 




PREDICTED: Rattus norvegicus similar 
to olfactory receptor 697 (LOC682377), 
partial mRNA [XM_001061252] 
 





Rattus norvegicus similar to RIKEN 
cDNA 1700026D08 (RGD1310371), mRNA 
[NM_001100581] 
chr1 










Ankyrin repeat and SOCS 




Rattus norvegicus dynein light chain 
roadblock-type 2 (Dynlrb2), mRNA 
[NM_001108451] 
chr19 





PREDICTED: Rattus norvegicus similar 
to predicted CDS, mechanosensory 
transduction channel NOMPC (1O503) 
(RGD1560151), mRNA [XM_576520] 
chr9 







Rattus norvegicus solute carrier family 
16, member 5 (monocarboxylic acid 
transporter 6) (Slc16a5), mRNA 
[NM_001109568] 
chr10 
solute carrier family 16, 
member 5 (monocarboxylic 




PREDICTED: Rattus norvegicus WD 
repeat domain 38 (Wdr38), mRNA 
[XM_575125] 




Rattus norvegicus similar to hypothetical 
protein MGC6835 (LOC500300), mRNA 
[NM_001024334] 
chr4 





Rattus norvegicus RIB43A domain with 
coiled-coils 2 (Ribc2), mRNA 
[NM_001013949] 
chr7 





Rattus norvegicus hypothetical protein 








Rattus norvegicus folate receptor 1 (adult) 
(Folr1), mRNA [NM_133527] 




Rattus norvegicus cysteine-rich, 








Rattus norvegicus myeloid leukemia 
factor 1 (Mlf1), mRNA [NM_001107680] 




Rattus norvegicus NOP2/Sun domain 
family, member 4 (Nsun4), mRNA 
[NM_001106678] 
chr5 





Rattus norvegicus solute carrier family 10 
(sodium/bile acid cotransporter family), 
chr14 
solute carrier family 10 
(sodium/bile acid 


















Rattus norvegicus calmodulin-like 4 
(Calml4), mRNA [NM_001127575] 




Rattus norvegicus EF hand domain 
family, member B (Efhb), mRNA 
[NM_001106879] 
chr9 





PREDICTED: Rattus norvegicus 
spermatogenesis associated glutamate 









Rattus norvegicus similar to hypothetical 
protein (RGD1310641), mRNA 
[NM_001079701] 
chr5 





Rattus norvegicus sperm associated 
antigen 6 (Spag6), mRNA 
[NM_001034960] 




Rattus norvegicus calcyphosine-like 





PREDICTED: Rattus norvegicus similar 
to butyrate-induced transcript 1 
(LOC688570), mRNA [XM_001067468] 
chrX 















Rattus norvegicus claudin 14 (Cldn14), 
mRNA [NM_001013429] 




Rattus norvegicus brachyury 2 (T2), 
mRNA [NM_001161835] 




Rattus norvegicus myelin protein zero 
(Mpz), mRNA [NM_017027] 




Rattus norvegicus similar to RIKEN 
cDNA 1700012B09 (RGD1561795), mRNA 
[NM_001109289] 
chr8 





Rattus norvegicus G protein-coupled 
receptor 171 (Gpr171), mRNA 
[NM_001109510] 
chr2 





PREDICTED: Rattus norvegicus similar 
to F35C5.3 (LOC687303), mRNA 
[XM_001077913] 




CR473051 Rat pBluescript Lion Rattus 
norvegicus cDNA clone LIONp463G03145 








Rattus norvegicus adenylate kinase 7 
(Ak7), mRNA [NM_001108055] 




Rattus norvegicus olfactory receptor 1239 
(Olr1239), mRNA [NM_001000811] 




Rattus norvegicus solute carrier family 5 
(iodide transporter), member 8 (Slc5a8), 
mRNA [NM_001191987] 
chr7 
solute carrier family 5 (iodide 




Rattus norvegicus olfactory receptor 1318 
(Olr1318), mRNA [NM_001001087] 




Rattus norvegicus WAP four-disulfide 
core domain 5 (Wfdc5), mRNA 
[NM_001106538] 
chr3 





PREDICTED: Rattus norvegicus similar 
to Gene model 784 (RGD1561693), 
miscRNA [XR_085950] 




Rattus norvegicus trace amine-associated 








Rattus norvegicus activating transcription 







Rattus norvegicus aurora kinase B 
(Aurkb), mRNA [NM_053749] 




Rattus norvegicus anoctamin 1, calcium 
activated chloride channel (Ano1), mRNA 
[NM_001107564] 
chr1 
anoctamin 1, calcium 




PREDICTED: Rattus norvegicus cell 
surface receptor FDFACT-like 
(LOC100360108), mRNA [XM_002727949] 
chr12 





Rattus norvegicus transmembrane 
protein 212 (Tmem212), transcript 
variant 2, mRNA [NM_001164439] 




Rattus norvegicus family with sequence 
similarity 25, member A (Fam25a), 
mRNA [NM_001134849] 
chr16 
family with sequence 




Rattus norvegicus SEC31 homolog B (S. 
cerevisiae) (Sec31b), mRNA 
[NM_001135713] 
chr1 





Rattus norvegicus hypothetical protein 








Rattus norvegicus RGD1565611 













Rattus norvegicus keratin 20 (Krt20), 
mRNA [NM_173128] 




Rattus norvegicus esophagus cancer-








Rattus norvegicus myosin, heavy chain 2, 
skeletal muscle, adult (Myh2), mRNA 
[NM_001135157] 
chr10 
myosin, heavy chain 2, 










Rattus norvegicus pleckstrin homology-








FM119812 etnohea Rattus norvegicus 
cDNA clone etnoheaP0047K24 3', mRNA 
sequence [FM119812] 
chr4 
similar to Anionic trypsin II 




PREDICTED: Rattus norvegicus similar 
to tumor suppressor candidate 5 
(LOC687797), mRNA [XM_001080179] 
chr12 





Rattus norvegicus ankyrin repeat and 
SOCS box-containing 16 (Asb16), mRNA 
[NM_001109048] 
chr10 





Rattus norvegicus similar to Proteasome 
subunit alpha type 7-like (RGD1311659), 
mRNA [NM_001108884] 
chr18 
similar to Proteasome 




Rattus norvegicus similar to 
epidermodysplasia verruciformis 2 
(LOC688276), mRNA [NM_001126301] 
 














Rattus norvegicus chitinase, acidic (Chia), 
mRNA [NM_207586] 











Rattus norvegicus similar to ribosomal 
protein S12 (RGD1561102), mRNA 
[NM_001106777] 
chr7 





Rattus norvegicus uroplakin 1B (Upk1b), 
mRNA [NM_001024253] 






PREDICTED: Rattus norvegicus similar 
to within bgcn homolog (LOC689337), 
miscRNA [XR_006618] 
chrUn 





Rattus norvegicus epididymal protein 3B 
(Eddm3b), mRNA [NM_178103] 




Rattus norvegicus myosin binding protein 
H-like (Mybphl), mRNA [NM_001014042] 
chr2 





Rattus norvegicus Cdon homolog (mouse) 
(Cdon), mRNA [NM_017358] 






Rattus norvegicus similar to hypothetical 
protein FLJ25414 (RGD1359156), mRNA 
[NM_001005531] 
chr10 





Rattus norvegicus acyl-CoA synthetase 









Rattus norvegicus syntaxin binding 
protein 2 (Stxbp2), mRNA [NM_031126] 




Rattus norvegicus general transcription 
factor IIIC, polypeptide 4 (Gtf3c4), mRNA 
[NM_001109473] 
chr3 
general transcription factor 






PREDICTED: Rattus norvegicus similar 
to extraembryonic, spermatogenesis, 
homeobox 1 (LOC679219), mRNA 
[XM_001055261] 
 
similar to extraembryonic, 




Rattus norvegicus membrane-spanning 4-
domains, subfamily A, member 8A 
(Ms4a8a), mRNA [NM_001108519] 
chr1 
membrane-spanning 4-





















Rattus norvegicus vomeronasal 2 
receptor, 48 (Vom2r48), mRNA 
[NM_001099514] 




Rattus norvegicus solute carrier family 
22, member 25 (Slc22a25), mRNA 
[NM_138908] 
chr1 







PREDICTED: Rattus norvegicus similar 
to Glycophorin (LOC688972), mRNA 
[XM_001069014] 




AE001111 A. fulgidus predicted coding 
region AF2391 {Archaeoglobus fulgidus 
DSM 4304} (exp=-1; wgp=0; cg=1), partial 
(26%) [TC624087] 
chr12 
AE001111 A. fulgidus 














PREDICTED: Rattus norvegicus similar 
to H3 histone, family 3B (LOC685984), 
mRNA [XM_001066068] 
chr4 





Rattus norvegicus cation channel, sperm-

















Rattus norvegicus potassium inwardly-
rectifying channel, subfamily J, member 
13 (Kcnj13), mRNA [NM_053608] 
chr9 
potassium inwardly-
rectifying channel, subfamily 




Rattus norvegicus olfactory receptor 1557 
(Olr1557), mRNA [NM_001000050] 




Rattus norvegicus polycystic kidney and 
hepatic disease 1-like 1 (Pkhd1l1), mRNA 
[NM_001034931] 
chr7 
polycystic kidney and hepatic 





C2p Rattus norvegicus cDNA clone UI-R-








Rattus norvegicus vomeronasal 2 
receptor, 72 (Vom2r72), mRNA 
[NM_001099517] 




Rattus norvegicus exocyst complex 
component 3-like 1 (Exoc3l1), mRNA 
[NM_001106178] 
chr19 





Rattus norvegicus meiosis expressed gene 
1 (Meig1), mRNA [NM_001134882] 








scavenger receptor cysteine 
rich domain containing, 




Rattus norvegicus zinc finger, DHHC-type 
containing 24 (Zdhhc24), mRNA 
[NM_001039100] 
chr1 





Rattus norvegicus myelin protein zero 
(Mpz), mRNA [NM_017027] 




Rattus norvegicus prostaglandin E 
receptor 3 (subtype EP3) (Ptger3), mRNA 
[NM_012704] 
chr2 





Rattus norvegicus crystallin, alpha A 
(Cryaa), mRNA [NM_012534] 













Rattus norvegicus zinc finger and BTB 
domain containing 2 (Zbtb2), mRNA 
[NM_001107460] 
chr1 





Rattus norvegicus urocortin 2 (Ucn2), 
mRNA [NM_133385] 






PREDICTED: Rattus norvegicus similar 
to hemicentin 1 (LOC688582), miscRNA 
[XR_085779] 




Rattus norvegicus sal-like 3 (Drosophila) 
(Sall3), mRNA [NM_001108892] 




Rattus norvegicus olfactory receptor 563 
(Olr563), mRNA [NM_001000666] 




Rattus norvegicus suppressor of cytokine 
signaling 1 (Socs1), mRNA [NM_145879] 
chr10 







Rattus norvegicus similar to RIKEN 
cDNA 4632419K20 (RGD1565007), mRNA 
[NM_001134592] 
chr2 





Rattus norvegicus TBC1 domain family, 
member 2 (Tbc1d2), mRNA 
[NM_001107933] 
chr5 





Rattus norvegicus early growth response 
2 (Egr2), mRNA [NM_053633] 













Rattus norvegicus MHC class I 
polypeptide-related sequence B (Micb), 
mRNA [NM_001017468] 
chr1 
MHC class I polypeptide-




Rattus norvegicus DEAH (Asp-Glu-Ala-
His) box polypeptide 33 (Dhx33), mRNA 
[NM_001105802] 
chr10 





Rattus norvegicus PHD finger protein 
21B (Phf21b), mRNA [NM_001130680] 




Rattus norvegicus RT1 class I, locus CE2 
(RT1-CE2), mRNA [NM_001008840] 






PREDICTED: Rattus norvegicus 
hypothetical protein LOC680813 








Rattus norvegicus tubulin tyrosine ligase-
like family, member 13 (Ttll13), mRNA 
[NM_001134962] 
chr1 
tubulin tyrosine ligase-like 






Rattus norvegicus similar to RIKEN 
cDNA 6430571L13 gene; similar to g20 
protein (RGD1307461), mRNA 
[NM_001106854] 
chr8 
similar to RIKEN cDNA 





Rattus norvegicus spermatogenesis 










Rattus norvegicus similar to testicular 
haploid expressed gene product isoform 2 
(LOC498350), mRNA [NM_001017498] 
chr14 
similar to testicular haploid 









zinc finger and SCAN 




Rattus norvegicus family with sequence 
similarity 64, member A (Fam64a), 
mRNA [NM_001113781] 
chr10 
family with sequence 






Rattus norvegicus similar to keratin 
complex 2, basic, gene 6a (LOC683313), 
mRNA [NM_001101007] 
 
similar to keratin complex 2, 






Rattus norvegicus similar to RIKEN 
cDNA 1700025E21 (RGD1559502), mRNA 
[NM_001109228] 
chr4 





Rattus norvegicus transcriptional adaptor 
2 (ADA2 homolog, yeast)-beta (Tada2b), 
mRNA [NM_001170455] 




Rattus norvegicus nitric oxide synthase 2, 
inducible (Nos2), mRNA [NM_012611] 
chr10 
















R-CN1 Rattus norvegicus cDNA clone UI-








Rattus norvegicus olfactory receptor 63 
(Olr63), mRNA [NM_001000542] 




Rattus norvegicus ATP-binding cassette, 
subfamily G (WHITE), member 3-like 4 
(Abcg3l4), mRNA [NM_001037205] 
chr14 random 
ATP-binding cassette, 
subfamily G (WHITE), 















Rattus norvegicus acyl-CoA synthetase 








Ig gamma-2B chain C region 
[Source:UniProtKB/Swiss-
Prot;Acc:P20761] 





Rattus norvegicus XK, Kell blood group 
complex subunit-related family, member 7 
(Xkr7), mRNA [NM_001012092] 
chr3 








Rattus norvegicus similar to dJ1016N21.1 
(novel protein (ortholog of Drosophila 
Pecanex (PCX), similar to KIAA0805)) 
(LOC307974), mRNA [XM_226603] 
chr19 random 
similar to dJ1016N21.1 
(novel protein (ortholog of 
Drosophila Pecanex (PCX), 




Rattus norvegicus sprouty homolog 3 
(Drosophila) (Spry3), mRNA 
[NM_001109063] 
chr12 





Rattus norvegicus family with sequence 
similarity 46, member C (Fam46c), mRNA 
[NM_001014041] 
chr2 
family with sequence 




Rattus norvegicus similar to beta-actin 
(LOC302340), mRNA [XM_228468] 

















Rattus norvegicus olfactory receptor 95 
(Olr95), mRNA [NM_001001024] 




Rattus norvegicus leukocyte specific 
transcript 1 (Lst1), mRNA [NM_022634] 
chr20 





Rattus norvegicus similar to Adapter-
related protein complex 1 sigma 1B 
subunit (Sigma-adaptin 1B) (Adaptor 
protein complex AP-1 sigma-1B subunit) 
(Golgi adaptor HA1/AP1 adaptin sigma-
1B subunit) (Clathrin assembly protein 
complex 1 sigma-1B small chain) (Sigma 
1B s... (LOC302671), mRNA [XM_217618] 
chrX 
similar to Adapter-related 
protein complex 1 sigma 1B 
















PREDICTED: Rattus norvegicus similar 
to OX-2 membrane glycoprotein precursor 
(MRC OX-2 antigen) (CD200 antigen) 
(LOC685716), mRNA [XM_001064969] 
chr11 
similar to OX-2 membrane 
glycoprotein precursor (MRC 





Rattus norvegicus similar to RIKEN 
cDNA 5830443L24 (LOC289446), mRNA 
[XM_223169] 
chr14 







PREDICTED: Rattus norvegicus similar 
to Glutathione S-transferase 8 (GST 8-8) 
(Chain 8) (GST class-alpha) 
(RGD1563185), mRNA [XM_576040] 
chr6 
similar to Glutathione S-







Rattus norvegicus similar to hypothetical 
protein FLJ25371 (LOC499643), mRNA 
[NM_001024301] 
chr2 





Rattus norvegicus transmembrane 










Rattus norvegicus hypothetical protein 








Rattus norvegicus SRY (sex determining 
region Y)-box 12 (Sox12), mRNA 
[NM_001168650] 
chr3 







Rattus norvegicus similar to testis 
expressed sequence 13B (RGD1563975), 
mRNA [NM_001195270] 
chrX 





Rattus norvegicus Cd5 molecule-like 
(Cd5l), mRNA [NM_001025685] 




PREDICTED: Rattus norvegicus similar 
to hypothetical protein D430020F16 
(RGD1560280), mRNA [XM_001063833] 
chr1 





PREDICTED: Rattus norvegicus similar 
to Gene model 784 (RGD1561693), 
miscRNA [XR_085950] 




Rattus norvegicus serine peptidase 
inhibitor, Kazal type 13 (Spink13), mRNA 
[NM_001109539] 
chr18 
serine peptidase inhibitor, 




Rattus norvegicus similar to chromosome 
6 open reading frame 148 (RGD1561909), 
mRNA [NM_001109334] 
chr1 
similar to chromosome 6 




Rattus norvegicus zinc finger, MYND-type 
containing 15 (Zmynd15), mRNA 
[NM_001105800] 
chr10 





Rattus norvegicus POM121 membrane 
glycoprotein-like 2 (Pom121l2), transcript 







PREDICTED: Rattus norvegicus similar 
to Transmembrane protein 16B, 
transcript variant 2 (LOC683001), mRNA 
[XM_001066415] 
chr4 
similar to Transmembrane 





Rattus norvegicus fucosyltransferase 1 
(Fut1), mRNA [NM_031236] 




Rattus norvegicus 5-hydroxytryptamine 








Shultzomica02182 Rat lung airway and 
parenchyma cDNA libraries Rattus 
norvegicus cDNA clone Contig1844 5', 
mRNA sequence [CF108931] 




Rattus norvegicus asparaginase homolog 
(S. cerevisiae) (Aspg), mRNA 
[NM_144750] 
chr6 





Rattus norvegicus frizzled family receptor 
4 (Fzd4), mRNA [NM_022623] 




Rattus norvegicus basonuclin 2 (Bnc2), 
mRNA [NM_001106666] 





NIH_MGC_252 Rattus norvegicus cDNA 
clone IMAGE:9111687 5', mRNA sequence 
[EX491611] 
chrUn 





PREDICTED: Rattus norvegicus 
hypothetical protein LOC100362274 









(10220) Rattus norvegicus cDNA clone 
srpb2-00196-f7 5', mRNA sequence 
[CB763787] 




Rattus norvegicus Fc receptor-like A 
(Fcrla), mRNA [NM_001100682] 




PREDICTED: Rattus norvegicus 
hypothetical protein LOC690347 







Rattus norvegicus chromosome 7, 38 
clones, strain BN/SsNHsdMCW 
RNOR03304491, whole genome shotgun 
sequence [AABR03059028] 
chr7 
chromosome 7, 38 clones, 
strain BN/SsNHsdMCW 
RNOR03304491, whole 











Rattus norvegicus serine peptidase 
inhibitor-like, with Kunitz and WAP 




like, with Kunitz and WAP 




Rattus norvegicus Rho GTPase activating 
protein 31 (Arhgap31), mRNA 
[NM_001105879] 
chr11 





AMGNNUC:NRHY4-00050-E9-AV W Rat 
hypothalamus (10464) Rattus norvegicus 
cDNA clone nrhy4-00050-e9, mRNA 
sequence [CB605923] 




Rattus norvegicus potassium inwardly-
rectifying channel, subfamily J, member 2 
(Kcnj2), mRNA [NM_017296] 
chr10 
potassium inwardly-
rectifying channel, subfamily 




Rattus norvegicus chemokine (C-C motif) 
ligand 21 (Ccl21), mRNA 
[NM_001008513] 
chr5 





Rattus norvegicus transglutaminase 1, K 
polypeptide (Tgm1), mRNA [NM_031659] 
chr15 













Rattus norvegicus coiled-coil domain 
containing 48 (Ccdc48), mRNA 
[NM_001163921] 
chr4 





Rattus norvegicus pyridoxal-dependent 
decarboxylase domain containing 1 








Rattus norvegicus nucleoredoxin-like 2 
(Nxnl2), mRNA [NM_001170429] 




Rattus norvegicus Max dimerization 
protein 3 (Mxd3), mRNA [NM_145773] 




Q5KT07_RAT (Q5KT07) Spetex-2C, 







Rattus norvegicus solute carrier family 6 
(neurotransmitter transporter, 
dopamine), member 3 (Slc6a3), mRNA 
[NM_012694] 
chr1 







Rattus norvegicus leiomodin 2 (cardiac) 
(Lmod2), mRNA [NM_001100964] 




Rattus norvegicus hairy and enhancer of 
split 5 (Drosophila) (Hes5), mRNA 
[NM_024383] 




PREDICTED: Rattus norvegicus 
transmembrane protein 71 (Tmem71), 
mRNA [XM_001075116] 




Rattus norvegicus vav 3 guanine 
nucleotide exchange factor (Vav3), mRNA 
[NM_001191714] 
chr2 





Rattus norvegicus solute carrier family 9 
(sodium/hydrogen exchanger), member 2 
(Slc9a2), transcript variant 1, mRNA 
[NM_001113335] 
chr9 
solute carrier family 9 
(sodium/hydrogen 




Rattus norvegicus potassium voltage-
gated channel, shaker-related subfamily, 

















PREDICTED: Rattus norvegicus similar 
to zinc finger protein 11B (LOC690146), 
mRNA [XM_001073454] 
chr1 





Rattus norvegicus gap junction protein, 
alpha 6 (Gja6), mRNA [NM_019308] 




Rattus norvegicus similar to RIKEN 
cDNA 4930511I11 (RGD1306008), mRNA 
[NM_001113777] 
chr20 
similar to RIKEN cDNA 
4930511I11 
Numerical values in this table mean the logarithm of [gene expression of group C]/ [gene 













Rattus norvegicus myelin protein zero-
like 2 (Mpzl2), mRNA [NM_001106818] 




Rattus norvegicus tissue factor pathway 
inhibitor (lipoprotein-associated 
coagulation inhibitor) (Tfpi), transcript 
variant 2, mRNA [NM_001177321] 
chr3 







PREDICTED: Rattus norvegicus similar 
to MAP/microtubule affinity-regulating 
kinase 4 (MAP/microtubule affinity-
regulating kinase like 1) (RGD1566047), 
mRNA [XM_574062] 
chr17 
similar to MAP/microtubule 
affinity-regulating kinase 4 
(MAP/microtubule affinity-




Rattus norvegicus wingless-type MMTV 
integration site family, member 2B 
(Wnt2b), mRNA [NM_001191848] 
chr2 
wingless-type MMTV 





Rattus norvegicus natriuretic peptide 
receptor C/guanylate cyclase C 
(atrionatriuretic peptide receptor C) 
(Npr3), mRNA [NM_012868] 
chr2 
natriuretic peptide receptor 












Rattus norvegicus aryl-hydrocarbon 








Rattus norvegicus CDC14 cell division 
cycle 14 homolog A (S. cerevisiae) 
(Cdc14a), transcript variant 2, mRNA 
[NM_001107718] 
chr2 
CDC14 cell division cycle 14 




PREDICTED: Rattus norvegicus Rap 
guanine nucleotide exchange factor (GEF) 
1 (Rapgef1), mRNA [XM_216018] 
chr3 
Rap guanine nucleotide 




Rattus norvegicus G protein-coupled 
receptor 22 (Gpr22), mRNA 
[NM_001106722] 




Rattus norvegicus inhibin beta-A (Inhba), 
mRNA [NM_017128] 




Rattus norvegicus cadherin 1 (Cdh1), 
mRNA [NM_031334] 




Rattus norvegicus deiodinase, 








Rattus norvegicus AT rich interactive 
domain 3C (BRIGHT-like) (Arid3c), 
mRNA [NM_001173981] 
chr5 





PREDICTED: Rattus norvegicus similar 
to GREB1 protein isoform a 
(RGD1562371), mRNA [XM_574101] 
chr18 





Rattus norvegicus collagen, type IV, alpha 
4 (Col4a4), mRNA [NM_001008332] 














Rattus norvegicus amylo-alpha-1, 6-
glucosidase, 4-alpha-glucanotransferase 







Rattus norvegicus Ab1-152 (LOC500877), 
mRNA [NM_001047963] 
chr7 Ab1-152 
Table S2. Examples of epilepsy-related genes with differential expression between 
group B (priming stimulation only) and group C (priming stimulation and test 





(Group C vs Group B) 
WT 
(Group C vs Group B) 
Kcnj13 
potassium inwardly-rectifying 
channel, subfamily J, member 13 
-1.17 < +-1.00 
Cryaa crystallin, alpha A -1.21 < +-1.00 
Egr early growth response 2 -1.32 < +-1.00 
Nos2 nitric oxide synthase 2, inducible -1.71 < +-1.00 
Tex28 testis expressed 28 2.32 < +-1.00 
Slc12a3 
solute carrier family 12 
(sodium/chloride transporters), 
member 3 
1.54 < +-1.00 
Drd2 dopamine receptor D2 1.41 < +-1.00 
Stam 
signal transducing adaptor 
molecule (SH3 domain and ITAM 
motif) 1 
1.13 < +-1.00 
Fzd4 frizzled family receptor 4 < +-1.00 1.73 
Kcnj2 
potassium inwardly-rectifying 
channel, subfamily J, member 2 
< +-1.00 1.38 
Slc6a3 
solute carrier family 6 
(neurotransmitter transporter, 
dopamine), member 3 
< +-1.00 1.22 
Hes5 hairy and enhancer of split 5 < +-1.00 1.17 
Tfpi 
tissue factor pathway inhibitor 
(lipoprotein-associated 
coagulation inhibitor) 
< +-1.00 1.07 
Rapgef1 
Rap guanine nucleotide exchange 
factor (GEF) 1 
< +-1.00 1.03 
Chrna7 
Neuronal acetylcholine receptor 
subunit alpha-7 




< +-1.00 1.00 
Opalin 
oligodendrocytic myelin paranodal 
and inner loop protein 
< +-1.00 -1.00 
Apod apolipoprotein D < +-1.00 -1.01 
Slc4a1 
solute carrier family 4 (anion 
exchanger), member 1 
< +-1.00 -1.01 
Pax4 paired box 4 < +-1.00 -1.02 
Nfil3 
nuclear factor, interleukin 3 
regulated 
< +-1.00 -1.04 








< +-1.00 -1.07 
Ntrk2 
neurotrophic tyrosine kinase, 
receptor, type 2 
< +-1.00 -1.07 
*Genes were found using PubMed, Sciverse Scopus and Web of Science, with the 
search terms ‘epilepsy and [gene name]’. Genes in boldface type have interaction 
with Lgi1 gene found by using STRING, with the search terms ‘Lgi1 and [gene 
name]’. Genes in underline type have weaker interaction with Lgi1. Numerical 
values in this table mean the logarithm of [gene expression of group C]/ [gene 
expression of group B] to base two.  
Gjc2 gap junction protein, gamma 2 < +-1.00 -1.08 
Fa2h fatty acid 2-hydroxylase < +-1.00 -1.14 
Cyp11a1 
cytochrome P450, family 11, 
subfamily a, polypeptide 1 
< +-1.00 -1.15 
Pign 
phosphatidylinositol glycan, class 
N 
< +-1.00 -1.15 
P2ry2 
purinergic receptor P2Y, G-
protein coupled, 2 
< +-1.00 -1.16 
Adamts4 
ADAM metallopeptidase with 
thrombospondin type 1 motif, 4 
< +-1.00 -1.19 
Cldn11 claudin 11 < +-1.00 -1.20 
Plp1 proteolipid protein 1 < +-1.00 -1.21 
Ngfr 
nerve growth factor receptor 
(TNFR superfamily, member 16)  
< +-1.00 -1.23 
Cd40 
CD40 molecule, TNF receptor 
superfamily member 5 
< +-1.00 -1.27 
Klk6 kallikrein related-peptidase 6 < +-1.00 -1.27 
Best1 bestrophin 1 < +-1.00 -1.33 
Klf4 Kruppel-like factor 4 (gut) < +-1.00 -1.42 
Fos FBJ osteosarcoma oncogene < +-1.00 -1.48 




< +-1.00 -1.56 
Dusp1 dual specificity phosphatase 1 < +-1.00 -1.66 
Pax9 paired box 9 < +-1.00 -1.68 
Kcnk16 
potassium channel, subfamily K, 
member 16 
< +-1.00 -1.83 
Folr1 folate receptor 1 (adult) < +-1.00 -2.10 
Slc10a4 
solute carrier family 10 
(sodium/bile acid cotransporter 
family), member 4 
< +-1.00 -2.21 
Atp7a Copper-transporting ATPase 1 < +-1.00 -2.45 
Slc19a3 
solute carrier family 19, member 
3 
1.43 2.02 
Zic4 Zic family member 4 1.07 1.14 
Nts neurotensin 2.36 -4.74 
Rgs9 regulator of G-protein signaling 9 1.79 -1.14 
Adora2a adenosine A2a receptor 1.69 -1.71 
Eln elastin -2.07 1.60 
Hdc histidine decarboxylase -2.02 -3.03 
Spef2 sperm flagellar 2 -1.11 -1.22 
Gins2 
GINS complex subunit 2 (Psf2 
homolog) 
-1.06 -1.42 
